- Research article
- Open Access
Microarray analysis identifies a common set of cellular genes modulated by different HCV replicon clones
© Ciccaglione et al; licensee BioMed Central Ltd. 2008
Received: 08 April 2008
Accepted: 30 June 2008
Published: 30 June 2008
Hepatitis C virus (HCV) RNA synthesis and protein expression affect cell homeostasis by modulation of gene expression. The impact of HCV replication on global cell transcription has not been fully evaluated. Thus, we analysed the expression profiles of different clones of human hepatoma-derived Huh-7 cells carrying a self-replicating HCV RNA which express all viral proteins (HCV replicon system).
First, we compared the expression profile of HCV replicon clone 21-5 with both the Huh-7 parental cells and the 21-5 cured (21-5c) cells. In these latter, the HCV RNA has been eliminated by IFN-α treatment. To confirm data, we also analyzed microarray results from both the 21-5 and two other HCV replicon clones, 22-6 and 21-7, compared to the Huh-7 cells. The study was carried out by using the Applied Biosystems (AB) Human Genome Survey Microarray v1.0 which provides 31,700 probes that correspond to 27,868 human genes. Microarray analysis revealed a specific transcriptional program induced by HCV in replicon cells respect to both IFN-α-cured and Huh-7 cells. From the original datasets of differentially expressed genes, we selected by Venn diagrams a final list of 38 genes modulated by HCV in all clones. Most of the 38 genes have never been described before and showed high fold-change associated with significant p-value, strongly supporting data reliability. Classification of the 38 genes by Panther System identified functional categories that were significantly enriched in this gene set, such as histones and ribosomal proteins as well as extracellular matrix and intracellular protein traffic. The dataset also included new genes involved in lipid metabolism, extracellular matrix and cytoskeletal network, which may be critical for HCV replication and pathogenesis.
Our data provide a comprehensive analysis of alterations in gene expression induced by HCV replication and reveal modulation of new genes potentially useful for selection of antiviral targets.
Infection with hepatitis C virus (HCV) represents the major cause of liver disease, affecting more than 170 million individuals worldwide. After a sub-clinical phase, greater than 80% of patients progress to persistent HCV infection which is the leading cause of chronic liver disease associated with cirrhosis and hepatocellular carcinoma [1, 2].
Research on HCV replication and pathogenesis has been hampered by the lack of reproducible in vitro methods of HCV infection. To overcome these restrictions, selectable HCV replicons in human hepatoma-derived Huh7 cells, which contain self-replicating HCV RNA and express all viral proteins, were developed [3–6]. These systems have been largely used for the study of HCV translation and RNA replication revealing important processes of virus-host interactions [7–12]. HCV proteins have been proposed to be involved in a wide range of activities, including cell signaling, transcriptional modulation, transformation, apoptosis, oxidative stress, membrane rearrangement, vesicular trafficking and immune response [13–21]. Recently, cell culture models that release HCV viral particles have been developed providing new possibilities for molecular studies of the HCV life cycle and virus-cell interactions [22–24]. Interestingly, a set of 26 human genes that modulate virus production have been identified by using a siRNA screening approach, suggesting the possibility to target host genes for antiviral therapy .
Microarray technology provides the opportunity to study HCV-host interactions at genomic level and identify novel genes relevant for HCV infection. Despite a large body of evidences suggesting that HCV affects cell homeostasis, a first microarray analysis revealed that HCV replicon exerts a minimal effect on host cell expression profile. On the other hand, this study indicated that a common transcriptional response to HCV could be detected in different clones of replicon cells. This response, however, involves only a limited number of mRNAs that show minor changes in the expression level and remains to be more fully elucidated .
Microarray is a rapidly implementing technology and the commercially available platforms show unique genomic targets and use different methodologies for probe design and for detection of signals, resulting in different level of sensitivity [27, 28]. Moreover, the final list of human genes has yet to be determined and reference sequences are periodically modified. On this basis, to identify cellular genes that are modulated by HCV RNA replication, we analyzed the expression profile of cell lines carrying a full-length HCV genome by a new microarray platform developed by the Applied Biosystems. To enhance the sensitivity to low abundance transcripts, this platform employs 60-mers oligonucleotides and a chemiluminescence-based approach to detection, with reduced background noise relative to standard fluorescent systems.
Present data indicated that the AB microarray shows the sensitivity to detect a higher number of cellular genes modulated by HCV in replicon cells respect to both cells cultured with IFN α, a treatment which has been shown to eliminate self-replicating HCV RNA , and Huh-7 cells. From the original datasets of differentially expressed genes, we selected 38 genes that show a concordant expression in three different HCV replicon clones and are potentially implicated in HCV infection. Our study also confirmed the involvement of previously identified cellular processes in HCV replication, and provided archived microarray databases useful for selection of new targets of antiviral therapy.
Modulation of gene expression in 21-5 cells carrying a full-length HCV replicon
Number of probes with significantly different expression (p ≤ 0.05)
21-5 vs. 21-5c (dataset 1)
21-5 vs. Huh-7 (dataset 2)
FC ≥ 2
Functional classification of genes altered by HCV in 21-5 replicon clone
Panther classification of biological processes, molecular functions and pathways significantly enriched in the set of 103 genes
Immunity and defense
T-cell mediated immunity
Blood circulation and gas exchange activity
Other blood circulation and gas exchange activity
Nucleoside. nucleotide and nucleic acid metabolism
Chromatin packaging and remodeling
Protein metabolism and modification
Amino acid metabolism
Cell structure and motility
Intracellular signaling cascade
Lipid. fatty acid and steroid metabolism
Fatty acid metabolism
Growth factor homeostasis
Other homeostasis activities
Nucleic acid binding
Extracellular matrix glycoprotein
Other extracellular matrix
Select calcium binding protein
Glutamine glutamate conversion
Selection of genes modulated by different HCV replicon clones
One of the major concern in HCV studies is that the observed findings might be due to clonal selection of replicon cells rather than HCV replication and expression. To exclude that differences in gene expression were exclusive of the 21-5 clone, we carried out a second analysis, including microarray results from both the 21-5 clone and two other HCV replicon clones, 22-6 and 21-7, as well as the Huh-7 cell line. Overall, we analysed data from eleven arrays: four replicates (two technical replicates for each one of two biological replicates) from both 21-5 and Huh-7 cell lines, two biological replicates from clone 21-7 and one from clone 22-6, for a total of seven HCV arrays and four Huh-7 arrays. The number of differentially expressed genes was evaluated by filtering data using a S/N ratio > 3.0 in 75% of replicates in at least one tested sample group and p ≤ 0.05. The analysis revealed that 725 current probes were modulated in HCV clones as compared to Huh-7 cells (dataset 3) (Fig. 1B). As shown in supplementary information [see Additional file 3], a hierarchical clustering analysis performed on this probe list correctly grouped biological and technical replicates among either the HCV clones or the Huh-7 cells. In addition, this analysis clearly depicted that, in spite of some differences between HCV clones, a common transcriptional response to HCV is well detectable. It is reasonable to suppose that HCV replication level may influence only in minimal part the variation in gene expression observed between clones. In fact, only a slight variation (1.6 fold) in HCV RNA amount was reported: the average replication levels of HCV RNA in the cell clones 21-5, 22-6 and 21-7 ranged between 1.5 to 2.5 × 107 molecules per μg of total RNA , levels that were confirmed in our laboratory.
To further select, among the 725 probes, only genes which were confirmed also in the comparison with the cured cells, we overlapped datasets 3 and 1. Of the 725 probes detected in dataset 3, 88 of them were in common with the 690 probes identified in dataset 1. Among these 88 probes, 58 (4.4%) out of 1,327 total probes showed concordant expression in all different HCV replicon clones respect to both cured and Huh-7 cell lines (Fig. 1B). As a final step, we found that 39 probes were common to the sets of 58 and 104 probes identified above: thus, 39 (31.7%) out of 123 probes were confirmed in all three comparisons (Fig. 1C). The 38 genes identified by those 39 probes are included, marked by gene symbol in bold, in the larger list of 57 genes identified by the above 58 probes, reported as supporting information [see Additional file 4]. Although the used strategy of analysis seriously reduced the number of differentially expressed probes, it led to 4 to 8 fold enrichment of probes showing concordant expression in different datasets (7.7% and 4.4% vs 31.7%, Fig. 1A, B and 1C). Modulation of 19 out of 58 probes did not reach statistical significance in dataset 2 (Fig. 1C) (the corresponding genes are marked by gene symbol in normal type in the list of 57 genes [see Additional file 4]). However, these genes were included in the subsequent ontological analysis as their modulation is highly significant in dataset 1 and 3.
Biological functions of selected genes modulated by HCV in different replicon clones
Panther classification of biological processes and molecular functions significantly enriched in the set of 57 genes
p-value with Bonferroni
Nucleoside, nucleotide and nucleic acid
Chromatin packaging and remodeling
Other mRNA transcription
Intracellular protein traffic
Nucleic acid binding
Extracellular matrix glycoprotein
Validation of microarray data by real-time RT-PCR
In the present work, we identified cellular genes which are modulated by HCV replication and protein expression by using a DNA microarray platform. This study represents the first global analysis that showed the sensitivity to reveal a common transcriptional response of Huh-7 cells to different clones of full-length HCV replicon. Specifically, we selected from the original datasets of differentially expressed genes, 38 genes that showed a concordant expression in three HCV replicon clones respect to both Huh-7 and IFN-α-cured cell lines.
Most of the 38 genes have never been described previously as relevant in HCV biology. To our knowledge, although modulation of SPP1, G1P2 and DDIT3 genes have been demonstrated in previous studies [34–37, 25], the impact of HCV replication on the other 36 genes has never been reported. In addition, gene ontology analysis of the 38 genes revealed regulation by HCV of new biological processes like chromatin packaging and chromosome segregation as well as the identification of new genes involved in previously identified pathways such as lipid metabolism, extracellular matrix constitution and cytoskeletal network. The discovery of these new genes and gene families has been made possible through our microarray study and may constitute the basis for additional experiments useful to provide new insights into the biology of the virus.
Consistent with our microarray data, proteome analysis of cells harboring HCV replicon revealed a virus-induced perturbation in host cell protein synthesis, including proteins associated with host cytoskeleton, intracellular protein traffic, oxidative and ER stress and lipid metabolism [38, 39]. Importantly, the down-regulation of enzymes involved in the mitochondrial ß-oxidation of fatty acids, such as carnitine palmitoyltransferase II (CPT2) and acyl-Coenzyme A dehydrogenase (ACADM), reported in proteome analysis  has been confirmed by our study (data not shown). This impaired mitochondrial function was also reported in a study describing a reduction in mitochondrial processes as a result of HCV-associated oxidative stress .
In a previous microarray analysis, the authors found that only 25 and 43 transcripts, respectively, differed in abundance by ≥ 2-fold (p ≤ 0.05) when two clones of HCV replicon were compared to the relative cured cell lines . In contrast, we found that 288 genes were differentially expressed with a fold change ≥ 2 (p ≤ 0.05) when HCV replicon clone 21-5 was compared to the 21-5 cured cells. This discrepancy could be explained by the different sensitivity of the used microarray platforms. Indeed, the AB platform was reported to be more sensitive respect to the Affymetrix platform, detecting four times as many genes in an identical experimental design, and over seven times when additional technical replicates were included . The higher sensitivity of the AB platform and the inclusion of four technical replicates for each samples, likely contributed to the increased number of differentially expressed genes that we detected.
Among the 38 selected genes modulated by HCV, we found that genes encoding DNA and RNA-binding proteins were significantly over-represented. Consistent with this observation, a larger proportion of genes encoding nucleic acid binding proteins have been found by microarray analysis in HCV-infected cirrhotic livers . Interestingly, four genes encoding histone proteins were up-regulated in this gene set. Three of these genes (HIST2H2AC, HIST2H2AA and HIST1H1C) showed a fold induction ≥ 2 and a highly significant associated p-value in all comparisons [see Additional file 4]. Importantly, in microarray data analysis fold-change alone is widely considered an invalid statistic test and it needs to be associated with its p-value . Therefore, the statistical significance of these results possibly suggests that modulation of histone genes represents a new HCV-induced pathway. To our knowledge, this is the first report coupling histone gene expression with HCV RNA replication. Interestingly, production of histone proteins is required to package DNA immediately upon initiation of DNA synthesis. As a consequence, transcription of histone genes takes place only at the onset of S-phase and it also respond to changes in rates of DNA synthesis [43, 44]. Studies aimed at investigating HCV replication revealed that synthesis of HCV RNA is stimulated in S-phase cells [6, 26]. Moreover, replication of viral RNA is regulated by the level of precursors of DNA synthesis, such as pyrimidine nucleosides, and/or the de novo synthesis of pyrimidines [45, 46]. On this basis, we speculated that stimulation of nucleic acid metabolism, and consequently histone synthesis, by HCV may be an advantageous mechanism for replication of viral RNA. The induction of histone genes in HCV replicon cells further support the existence of a link between regulation of cell cycle and HCV RNA synthesis and requires further investigation.
As previously reported in HCV patients , genes encoding components of the extracellular matrix (ECM) were over-represented in the HCV gene set. The confirmation of in vivo data by microarray, clearly supports the biological significance of our study. One of these genes (SPP1) showed elevated levels of induction (fold > 3.9) associated with significant p-values [see Additional file 4]. Importantly, SPP1 and other genes implicated in the ECM turnover were up-regulated in the transition from mild to moderate fibrosis in HCV chronic patients and they have been proposed as new potential targets for antifibrosis drug development . In addition, elevated serum levels of osteopontin, the protein encoded by SPP1, were found in HCV-associated B-cell nonHodgkin's lymphoma and type II mixed cryoglobulinemia . Osteopontin is a secreted glycoprotein with a wide spectrum of biological activities promoting cell adhesion, migration, ECM invasion . Evidences point to a central role for osteopontin in liver fibrosis as it induces hepatic stellate cell (HSC) migration and proliferation and stimulates synthesis of matrix metalloproteinase 2 (MMP-2) and type I collagen by HSC . Consequently, modulation of SPP1 by HCV may be critical for liver fibrosis development and represents a potential target for therapy of HCV infection and/or disease progression.
In a recent report, it was shown that HCV RNA synthesis required an intact cytoskeleton, as inhibition of microtubule and actin polymerization resulted in decreased HCV replication . Our microarray data indicated that three cytoskeletal genes (TUBB2A, CENPE, MTSS1) are significantly modulated by HCV replication. Tubulin beta 2A (TUBB2A), a structural constituent of microtubules, is up-regulated in HCV replicon cells as well as CENPE and MTSS1 genes both encoding for cytoskeletal proteins which bind to microtubule (CENPE) and actin (MTSS1) structures. The identification of these additional genes confirms the potential link between HCV RNA synthesis and cytoskeletal network.
Several evidences indicate that HCV induces alterations in lipid metabolism and contributes to the development of oxidative stress [13, 14, 40, 50, 33, 11, 12]. Consistent with this observation, in the dataset of 38 genes we found two genes, DDIT3 and ELOVL6, which are involved in oxidative stress induction and lipid biosynthesis, respectively.
Activation of the pro-apoptotic gene DDIT3, also known as Gadd153, by HCV has been previously demonstrated [35, 36, 15]. Elevated levels of Gadd153 protein in HCV replicon cells increased the sensitivity of these cells to oxidative stress suggesting that dysregulation of Gadd153 expression may be an important factor in HCV liver pathogenesis .
Recent reports suggest that increased synthesis of fatty acids enhances HCV replication . More than 90% of fatty acids presents in cells possess chain lengths of 16 (palmitic acid) and 18 (stearic acid) carbons. The palmitic acid is synthesized by fatty acid synthase (FAS) in the cytosol. A high proportion of this palmitic acid (C16) is then converted to stearic acid (C18) in the endoplasmic reticulum (ER) by the enzyme, ELOVL6, which initiates the elongation of C16 to C18 fatty acids . Interestingly, we found for the first time modulation of this gene in the HCV replicon cells. The robust down-regulation of ELOVL6 in our microarray dataset (fold change ≤ -2, p ≤ 0.008 in all comparisons) suggests that inhibition of this step would contribute to the accumulation of the upstream intermediate (palmitic acid), thus favouring HCV RNA synthesis. Although, it is now clear that lipid metabolism affects HCV replication, the role of ELOVL6 has not been investigated before and further experiments are needed to determine whether over-expression of ELOVL6 can inhibit HCV replication.
Our microarray analysis provided an overview of alterations in gene expression induced by HCV even in different replicon clones. The resulting databases from microarray experiments contained additional information which may be useful for future investigations. Indeed, gene ontology classified HCV-modulated genes into functional categories which are relevant for viral biology and pathogenesis, such as immunity, oncogenesis, NF-kappaB cascade, lipid metabolism, extracellular matrix and cytoskeletal network. But, most importantly, these functional groups also contained genes which have not previously been reported to be impacted by HCV replication. In addition, we identified new functional categories such as histones, signalling molecules, select calcium binding proteins and cell motility as well as genes involved in Glutamine glutamate conversion and Blood coagulation pathways. Finally, we also provided a list of 38 genes which have been confirmed to be differentially expressed in all HCV clones. The future design of siRNAs directed against some of these genes might be useful to evaluate their importance in regulating HCV replication, providing an experimental background for selection of new antiviral drugs
The Huh-7 cells carrying the Sfl HCV full-length replicon (genotype 1b) were obtained from Dr. R. Bartenschlager. The cell lines that stably replicates the HCV replicon were the 21-5, 21-7 and 22-6 clones passaged as described [53, 6]. Cured 21-5 replicon cells (21-5c) were obtained by treatment with 100U IFN-α/ml for 14 days, to eliminate self-replicating full-length HCV replicon. Clearance of replicon RNA was confirmed by RT-PCR and by loss of resistance to G418 . HCV replicon cells were cultured in complete DMEM supplemented with 10% FCS, antibiotics, 1× non-essential amino acids, and 250 μg/ml (21-5, 21-7) and 500 μg/ml (22-6) G418 [53, 6].
AB expression array system analysis
Total RNA was extracted from 1× 106 cells using RNeasy kits (Quiagen) as described by the manufacturer. The quality of RNA was evaluated using the Agilent Bioanalyzer 2100 (Agilent Technologies). Only high quality RNA samples with a minimum RNA Integrity Number (RIN) value of 8 were considered for RNA labeling. One μg of total RNA from each sample was used to synthesize digoxigenin-UTP-labeled cRNA as described by the Applied Biosystems (AB) Chemiluminescent RT-IVT Labeling protocol. Array hybridization, array processing, chemiluminescence detection, image acquisition, and analysis were performed using AB Chemiluminescent Detection Kit and AB1700 Chemiluminescent Microarray Analyzer following manufacturer's protocol. These protocols are detailed in the Chemiluminescent Microarray analyzer Chemistry Guide (P/N 4338853) , Chemiluminescent Detection Kit (P/N 4339627) , and Chemiluminescent Microarray Analyzer User Guide (P/N 4338852B). The probe sequences are available at Panther website . For each gene, the expression values were normalized across arrays by quantile normalization. "Detectable" calls for gene expression were based on Applied Biosystems recommendations (signal/noise ratio > 3.0 and FLAG values < 5000). A probe had to be called "detectable" in 75% of replicates in at least one tested sample group to be retained for further analysis. For each gene, expression fold-changes between groups were derived from the mean expression level in all replicates. P-values are derived from simple t-tests using log2 intensity data assuming equal variance. Hierarchical clustering analysis was performed in the Spotfire DecisionSite 9.1.1 (TIBCO Spotfire) software package, using the Unweighted Pair-Group Method with Arithmetic mean (UPGMA) as clustering method and Pearson's correlation as similarity measure.
Microarray data have been submitted to the ArrayExpress database . Accession number for the data is E-MEXP-1686.
Gene network pathway analysis
Gene Ontology (GO) annotations were analyzed with the Panther Protein Classification System  to identify functional annotations that were significantly enriched in this gene set compared to the entire human genome. Gene lists modulated by HCV were mapped onto biological pathways that were significantly represented.
TaqMan assay validation
Total RNA was extracted from 1 × 106 cells using RNeasy kit (Qiagen) as described by the manufacturer and quantified by Bioanalyzer 2100 (Agilent Technologies). One hundred nanograms of total RNA was reverse transcribed using the high-capacity cDNA Archive Kit (Applied Biosystems), with random hexamer primers in a ABI Prism 7000 Sequence Detection System (Applied Biosystems) using the following thermal profile: 25°C for 10 min, 42°C for 1 h and 95°C for 5 min. PCR reactions were performed in triplicate on the ABI Prism 7000 Sequence Detection System (Applied Biosystems) using TaqMan chemistry with primer and probe sets from the Assay-on-Demand list (Applied Biosystems). The standard curve of each gene was compared to the standard curve of the housekeeping GAPDH gene and calculation of the slope of log [ng RNA] vs. ΔCt was always < 0.1. Fold induction was then calculated by ΔΔCt method  using GAPDH mRNA level to normalize values and the mRNA level of 21-5 cured cell line as a calibrator. Data are expressed as fold-changes.
The authors are grateful to Dr. Ralph Bartenschlager for the 21-5, 21-7 and 22-6 HCV replicon cell lines, Sabrina Tocchio for excellent editorial and secretarial assistance and Roberto Gilardi for careful artwork.
- Hoofnagle JH: Hepatitis C: the clinical spectrum of disease. Hepatology. 1997, 26: 15S-20S. 10.1002/hep.510260703.PubMedView ArticleGoogle Scholar
- Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med. 2001, 345: 41-52. 10.1056/NEJM200107053450107. ReviewPubMedView ArticleGoogle Scholar
- Blight KJ, McKeating JA, Marcotrigiano J, Rice CM: Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol. 2003, 77: 3181-3190. 10.1128/JVI.77.5.3181-3190.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Ikeda M, Yi M, Li K, Lemon SM: Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol. 2002, 76: 2997-3006. 10.1128/JVI.76.6.2997-3006.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999, 285: 110-113. 10.1126/science.285.5424.110.PubMedView ArticleGoogle Scholar
- Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R: Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol. 2002, 76: 4008-4021. 10.1128/JVI.76.8.4008-4021.2002.PubMedPubMed CentralView ArticleGoogle Scholar
- Ciccaglione AR, Stellacci E, Marcantonio C, Muto V, Equestre M, Marsili G, Rapicetta M, Battistini A: Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol. 2007, 81: 202-214. 10.1128/JVI.01011-06.PubMedPubMed CentralView ArticleGoogle Scholar
- Kanazawa N, Kurosaki M, Sakamoto N, Enomoto N, Itsui Y, Yamashiro T, Tanabe Y, Maekawa S, Nakagawa M, Chen CH, Kakinuma S, Oshima S, Nakamura T, Kato T, Wakita T, Watanabe M: Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol. 2004, 78: 9713-9720. 10.1128/JVI.78.18.9713-9720.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Tardif KD, Mori K, Kaufman RJ, Siddiqui A: Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J Biol Chem. 2004, 279: 17158-17164. 10.1074/jbc.M312144200.PubMedView ArticleGoogle Scholar
- Tellinghuisen TL, Rice CM: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol. 2002, 5: 419-427. 10.1016/S1369-5274(02)00341-7.PubMedView ArticleGoogle Scholar
- Waris G, Siddiqui A: Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J Virol. 2005, 79: 9725-9734. 10.1128/JVI.79.15.9725-9734.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Waris G, Turkson J, Hassanein T, Siddiqui A: Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol. 2005, 79: 1569-1580. 10.1128/JVI.79.3.1569-1580.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Basu A, Meyer K, Lai KK, Saito K, Di Bisceglie AM, Grosso LE, Ray RB, Ray R: Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes. Virology. 2006, 349: 347-58. 10.1016/j.virol.2006.02.023.PubMedView ArticleGoogle Scholar
- Chang ML, Yeh CT, Chen JC, Huang CC, Lin SM, Sheen IS, Tai DI, Chu CM, Lin WP, Chang MY, Liang CK, Chiu CT, Lin DY: Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, non-obese, modest hepatic steatosis. BMC Genomics. 2008, 9: 109-117. 10.1186/1471-2164-9-109.PubMedPubMed CentralView ArticleGoogle Scholar
- Ciccaglione AR, Costantino A, Tritarelli E, Marcantonio C, Equestre M, Marziliano N, Rapicetta M: Activation of endoplasmic reticulum stress response by hepatitis C virus proteins. Arch Virol. 2005, 150: 1339-1356. 10.1007/s00705-004-0487-4.PubMedView ArticleGoogle Scholar
- Girard S, Vossman E, Misek DE, Podevin P, Hanash S, Brechot C, Beretta L: Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology. 2004, 40: 708-718. 10.1002/hep.20371.PubMedView ArticleGoogle Scholar
- Gong G, Waris G, Tanveer R, Siddiqui A: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA. 2001, 98: 9599-9604. 10.1073/pnas.171311298.PubMedPubMed CentralView ArticleGoogle Scholar
- Korenaga M, Wang T, Li Y, Showalter LA, Chan T, Sun J, Weinman SA: Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem. 2005, 280: 37481-37488. 10.1074/jbc.M506412200.PubMedView ArticleGoogle Scholar
- Li Y, Boehning DF, Qian T, Popov VL, Weinman SA: Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J. 2007, 21: 2474-2485. 10.1096/fj.06-7345com.PubMedView ArticleGoogle Scholar
- Nguyen H, Sankaran S, Dandekar S: Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology. 2006, 354: 58-68. 10.1016/j.virol.2006.04.028.PubMedView ArticleGoogle Scholar
- Ohkawa K, Ishida H, Nakanishi F, Hosui A, Ueda K, Takehara T, Hori M, Hayashi N: Hepatitis C virus core functions as a suppressor of cyclin-dependent kinase-activating kinase and impairs cell cycle progression. J Biol Chem. 2004, 279: 11719-11726. 10.1074/jbc.M308560200.PubMedView ArticleGoogle Scholar
- Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science. 2005, 309: 623-626. 10.1126/science.1114016.PubMedView ArticleGoogle Scholar
- Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005, 11: 791-796. 10.1038/nm1268.PubMedPubMed CentralView ArticleGoogle Scholar
- Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA. 2005, 102: 9294-9299. 10.1073/pnas.0503596102.PubMedPubMed CentralView ArticleGoogle Scholar
- Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM: Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA. 2007, 104: 12884-12889. 10.1073/pnas.0704894104.PubMedPubMed CentralView ArticleGoogle Scholar
- Scholle F, Li K, Bodola F, Ikeda M, Luxon BA, Lemon SM: Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol. 2004, 78: 1513-1524. 10.1128/JVI.78.3.1513-1524.2004.PubMedPubMed CentralView ArticleGoogle Scholar
- Ali-Seyed M, Laycock N, Karanam S, Xiao W, Blair ET, Moreno CS: Cross-platform expression profiling demonstrates that SV40 small tumor antigen activates Notch, Hedgehog, and Wnt signaling in human cells. BMC Cancer. 2006, 6: 54-67. 10.1186/1471-2407-6-54.PubMedPubMed CentralView ArticleGoogle Scholar
- Shi L, MAQC Consortium: The Microarray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nature Biotechnol. 2006, 24: 1151-1160. 10.1038/nbt1239.View ArticleGoogle Scholar
- Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H, Thomas PD: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 2005, 33: D284-D288. 10.1093/nar/gki078.PubMedPubMed CentralView ArticleGoogle Scholar
- Cho RJ, Campbell MJ: Transcription, genomes, function. Trends Genet. 2000, 16: 409-415. 10.1016/S0168-9525(00)02065-5. ReviewPubMedView ArticleGoogle Scholar
- Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D: An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003, 11: 619-633. 10.1016/S1097-2765(03)00105-9.PubMedView ArticleGoogle Scholar
- Okada T, Yoshida H, Akazawa R, Negishi M, Mori K: Distinct roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the mammalian unfolded protein response. Biochem J. 2002, 366: 585-594. 10.1042/BJ20020391.PubMedPubMed CentralView ArticleGoogle Scholar
- Tardif KD, Waris G, Siddiqui A: Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 2005, 13: 159-163. 10.1016/j.tim.2005.02.004.PubMedView ArticleGoogle Scholar
- Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, Degott C, Martinot M, Bedossa P, Valla D, Vidaud M, Marcellin P: Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology. 2005, 129: 2064-2075. 10.1053/j.gastro.2005.09.010.PubMedView ArticleGoogle Scholar
- Benali-Furet NL, Chami M, Houel L, De Giorgi F, Vernejoul F, Lagorce D, Buscail L, Bartenschlager R, Ichas F, Rizzuto R, Paterlini-Brechot P: Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene. 2005, 24: 4921-4933. 10.1038/sj.onc.1208673.PubMedView ArticleGoogle Scholar
- Ciccaglione AR, Marcantonio C, Tritarelli E, Equestre M, Vendittelli F, Costantino A, Geraci A, Rapicetta M: Activation of the ER stress gene gadd153 by hepatitis C virus sensitizes cells to oxidant injury. Virus Res. 2007, 126: 128-138. 10.1016/j.virusres.2007.02.006.PubMedView ArticleGoogle Scholar
- Libra M, Indelicato M, De Re V, Zignego AL, Chiocchetti A, Malaponte G, Dianzani U, Nicoletti F, Stivala F, McCubrey JA, Mazzarino MC: Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders. Cancer Biol Ther. 2005, 4: 1192-1194.PubMedView ArticleGoogle Scholar
- Fang C, Yi Z, Liu F, Lan S, Wang J, Lu H, Yang P, Yuan Z: Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon. Proteomics. 2006, 6: 519-527. 10.1002/pmic.200500233.PubMedView ArticleGoogle Scholar
- Jacobs JM, Diamond DL, Chan EY, Gritsenko MA, Qian W, Stastna M, Baas T, Camp DG, Carithers RL, Smith RD, Katze MG: Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol. 2005, 79: 7558-7569. 10.1128/JVI.79.12.7558-7569.2005.PubMedPubMed CentralView ArticleGoogle Scholar
- Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002, 122: 366-375. 10.1053/gast.2002.30983.PubMedView ArticleGoogle Scholar
- Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL, Katze MG: Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology. 2003, 38: 1458-1467.PubMedView ArticleGoogle Scholar
- Allison DB, Cui X, Page GP, Sabripour M: Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet. 2006, 7: 55-65. 10.1038/nrg1749. ReviewPubMedView ArticleGoogle Scholar
- Gunjan A, Paik J, Verreault A: Regulation of histone synthesis and nucleosome assembly. Biochimie. 2005, 87: 625-635. 10.1016/j.biochi.2005.02.008. ReviewPubMedView ArticleGoogle Scholar
- Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Zaidi SK, Braastad C: An architectural perspective of cell-cycle control at the G1/S phase cell-cycle transition. J Cell Physiol. 2006, 209: 706-710. 10.1002/jcp.20843. ReviewPubMedView ArticleGoogle Scholar
- Nelson HB, Tang H: Effect of cell growth on hepatitis C virus (HCV) replication and a mechanism of cell confluence-based inhibition of HCV RNA and protein expression. J Virol. 2006, 80: 1181-1190. 10.1128/JVI.80.3.1181-1190.2006.PubMedPubMed CentralView ArticleGoogle Scholar
- Stuyver LJ, McBrayer TR, Tharnish PM, Hassan AE, Chu CK, Pankiewicz KW, Watanabe KA, Schinazi RF, Otto MJ: Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites. J Virol. 2003, 77: 10689-10694. 10.1128/JVI.77.19.10689-10694.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS: The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 2006, 17: 463-474. 10.1016/j.cytogfr.2006.09.010.PubMedView ArticleGoogle Scholar
- Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH: Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol. 2004, 68: 2367-2378. 10.1016/j.bcp.2004.08.022.PubMedView ArticleGoogle Scholar
- Bost AG, Venable D, Liu L, Heinz BA: Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system. J Virol. 2003, 77: 4401-4408. 10.1128/JVI.77.7.4401-4408.2003.PubMedPubMed CentralView ArticleGoogle Scholar
- Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG, Chisari FV: Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA. 2002, 99: 15669-15674. 10.1073/pnas.202608199.PubMedPubMed CentralView ArticleGoogle Scholar
- Kapadia SB, Chisari FV: Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fattyacids. Proc Natl Acad Sci USA. 2005, 102: 2561-2566. 10.1073/pnas.0409834102.PubMedPubMed CentralView ArticleGoogle Scholar
- Moon YA, Shah NA, Mohapatra S, Warrington JA, Horton JD: Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem. 2001, 276: 45358-45366. 10.1074/jbc.M108413200.PubMedView ArticleGoogle Scholar
- Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O, Bartenschlager R: Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology. 2002, 35: 694-703. 10.1053/jhep.2002.31770.PubMedView ArticleGoogle Scholar
- User manual downloadable from Applied Biosystem website. [http://docs.appliedbiosystems.com/pebiodocs/04338853.pdf]
- User manual downloadable from Applied Biosystem website. [http://docs.appliedbiosystems.com/pebiodocs/04339627.pdf]
- PANTHER Classification System website. [http://www.pantherdb.org]
- ArrayExpress website. [http://www.ebi.ac.uk/arrayexpress]
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.